BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 23410059)

  • 1. Low/negative expression of DDX3 might predict poor prognosis in non-smoker patients with oral cancer.
    Lee CH; Lin SH; Yang SF; Yang SM; Chen MK; Lee H; Ko JL; Chen CJ; Yeh KT
    Oral Dis; 2014 Jan; 20(1):76-83. PubMed ID: 23410059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DDX3 promotes tumor invasion in colorectal cancer via the CK1ε/Dvl2 axis.
    He TY; Wu DW; Lin PL; Wang L; Huang CC; Chou MC; Lee H
    Sci Rep; 2016 Feb; 6():21483. PubMed ID: 26892600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DDX3 modulates cell adhesion and motility and cancer cell metastasis via Rac1-mediated signaling pathway.
    Chen HH; Yu HI; Cho WC; Tarn WY
    Oncogene; 2015 May; 34(21):2790-800. PubMed ID: 25043297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
    Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
    Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DDX3 regulates DNA damage-induced apoptosis and p53 stabilization.
    Sun M; Zhou T; Jonasch E; Jope RS
    Biochim Biophys Acta; 2013 Jun; 1833(6):1489-97. PubMed ID: 23470959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA helicase DDX3 is a regulatory subunit of casein kinase 1 in Wnt-β-catenin signaling.
    Cruciat CM; Dolde C; de Groot RE; Ohkawara B; Reinhard C; Korswagen HC; Niehrs C
    Science; 2013 Mar; 339(6126):1436-41. PubMed ID: 23413191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic lethal interactions of DEAD/H-box helicases as targets for cancer therapy.
    Arna AB; Patel H; Singh RS; Vizeacoumar FS; Kusalik A; Freywald A; Vizeacoumar FJ; Wu Y
    Front Oncol; 2022; 12():1087989. PubMed ID: 36761420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DEAD-Box RNA Helicases DDX3X and DDX5 as Oncogenes or Oncosuppressors: A Network Perspective.
    Secchi M; Lodola C; Garbelli A; Bione S; Maga G
    Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DEAD/H-Box Helicases in Immunity, Inflammation, Cell Differentiation, and Cell Death and Disease.
    Samir P; Kanneganti TD
    Cells; 2022 May; 11(10):. PubMed ID: 35626643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic DDX3 as prognosticator in male breast cancer.
    van der Pol CC; Moelans CB; Manson QF; Batenburg MCT; van der Wall E; Borel Rinkes I; Verkooijen L; Raman V; van Diest PJ
    Virchows Arch; 2021 Oct; 479(4):647-655. PubMed ID: 33974127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RB1, p16, and Human Papillomavirus in Oropharyngeal Squamous Cell Carcinoma.
    Berdugo J; Rooper LM; Chiosea SI
    Head Neck Pathol; 2021 Dec; 15(4):1109-1118. PubMed ID: 33830464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DDX3X: structure, physiologic functions and cancer.
    Mo J; Liang H; Su C; Li P; Chen J; Zhang B
    Mol Cancer; 2021 Feb; 20(1):38. PubMed ID: 33627125
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Lin TC
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the anatomical location, alcoholism and smoking on the prevalence of advanced oral cancer in Brazil.
    Bezerra NV; Leite KL; de Medeiros MM; Martins ML; Cardoso AM; Alves PM; Padilha WW; Cavalcanti YW
    Med Oral Patol Oral Cir Bucal; 2018 May; 23(3):e295-e301. PubMed ID: 29680854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical Differences and Similarities between the DEAD-Box Helicase Orthologs DDX3X and Ded1p.
    Sharma D; Putnam AA; Jankowsky E
    J Mol Biol; 2017 Nov; 429(23):3730-3742. PubMed ID: 29037760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DEAD-Box RNA Helicase DDX3 Interacts with NF-κB Subunit p65 and Suppresses p65-Mediated Transcription.
    Xiang N; He M; Ishaq M; Gao Y; Song F; Guo L; Ma L; Sun G; Liu D; Guo D; Chen Y
    PLoS One; 2016; 11(10):e0164471. PubMed ID: 27736973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DDX3X promotes the biogenesis of a subset of miRNAs and the potential roles they played in cancer development.
    Zhao L; Mao Y; Zhao Y; He Y
    Sci Rep; 2016 Sep; 6():32739. PubMed ID: 27586307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional DDX3: dual roles in various cancer development and its related signaling pathways.
    Zhao L; Mao Y; Zhou J; Zhao Y; Cao Y; Chen X
    Am J Cancer Res; 2016; 6(2):387-402. PubMed ID: 27186411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDX3, a potential target for cancer treatment.
    Bol GM; Xie M; Raman V
    Mol Cancer; 2015 Nov; 14():188. PubMed ID: 26541825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer.
    Heerma van Voss MR; Vesuna F; Trumpi K; Brilliant J; Berlinicke C; de Leng W; Kranenburg O; Offerhaus GJ; Bürger H; van der Wall E; van Diest PJ; Raman V
    Oncotarget; 2015 Sep; 6(29):28312-26. PubMed ID: 26311743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.